StreetInsider.com Pre-Open Movers:

AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) 17% HIGHER; announced the signing of an extended collaborative research and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE